Ameriprise’s Diebold Nixdorf Incorporated DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-32,333
Closed -$38.8K 4041
2023
Q1
$38.8K Buy
32,333
+16,788
+108% +$37.3K ﹤0.01% 3880
2022
Q4
$22K Sell
15,545
-321,399
-95% -$690K ﹤0.01% 3891
2022
Q3
$816K Sell
336,944
-263,991
-44% -$881K ﹤0.01% 3204
2022
Q2
$1.36M Buy
600,935
+171,360
+40% +$638K ﹤0.01% 2983
2022
Q1
$2.89M Buy
429,575
+26,694
+7% +$228K ﹤0.01% 2748
2021
Q4
$3.65M Buy
402,881
+47,053
+13% +$437K ﹤0.01% 2680
2021
Q3
$3.6M Sell
355,828
-14,599
-4% -$160K ﹤0.01% 2601
2021
Q2
$4.76M Sell
370,427
-15,764
-4% -$216K ﹤0.01% 2486
2021
Q1
$5.46M Sell
386,191
-4,369
-1% -$60.2K ﹤0.01% 2353
2020
Q4
$4.16M Buy
390,560
+20,935
+6% +$190K ﹤0.01% 2392
2020
Q3
$2.82M Sell
369,625
-10,892
-3% -$80.1K ﹤0.01% 2465
2020
Q2
$2.31M Sell
380,517
-13,453
-3% -$66.4K ﹤0.01% 2533
2020
Q1
$1.39M Sell
393,970
-26,560
-6% -$225K ﹤0.01% 2671
2019
Q4
$4.44M Sell
420,530
-10,509
-2% -$93.3K ﹤0.01% 2306
2019
Q3
$4.83M Sell
431,039
-9,058
-2% -$107K ﹤0.01% 2231
2019
Q2
$4.03M Sell
440,097
-8,292
-2% -$86.5K ﹤0.01% 2367
2019
Q1
$4.96M Buy
448,389
+24,445
+6% +$171K ﹤0.01% 2232
2018
Q4
$1.06M Sell
423,944
-6,971
-2% -$25K ﹤0.01% 2921
2018
Q3
$1.94M Buy
430,915
+10,033
+2% +$73.2K ﹤0.01% 2825
2018
Q2
$5.03M Buy
420,882
+185,196
+79% +$2.48M ﹤0.01% 2236
2018
Q1
$3.63M Buy
235,686
+25,426
+12% +$425K ﹤0.01% 2396
2017
Q4
$3.44M Sell
210,260
-3,102
-1% -$60K ﹤0.01% 2371
2017
Q3
$4.88M Sell
213,362
-464,138
-69% -$9.89M ﹤0.01% 2105
2017
Q2
$18.9M Sell
677,500
-36,406
-5% -$1.01M 0.01% 1055
2017
Q1
$21.9M Buy
713,906
+166,567
+30% +$4.7M 0.01% 953
2016
Q4
$13.8M Sell
547,339
-38,518
-7% -$908K 0.01% 1260
2016
Q3
$14.5M Buy
585,857
+116,149
+25% +$3.08M 0.01% 1148
2016
Q2
$11.7M Buy
469,708
+42,983
+10% +$1.11M 0.01% 1270
2016
Q1
$12.3M Sell
426,725
-50,040
-10% -$1.31M 0.01% 1262
2015
Q4
$14.3M Buy
476,765
+319,500
+203% +$10.9M 0.01% 1167
2015
Q3
$4.68M Sell
157,265
-2,296
-1% -$74.6K ﹤0.01% 2054
2015
Q2
$5.58M Buy
159,561
+3,128
+2% +$110K ﹤0.01% 2074
2015
Q1
$5.55M Buy
156,433
+5,142
+3% +$173K ﹤0.01% 2040
2014
Q4
$5.24M Sell
151,291
-4,159
-3% -$147K ﹤0.01% 2017
2014
Q3
$5.49M Buy
155,450
+1,257
+0.8% +$47.4K ﹤0.01% 1966
2014
Q2
$6.19M Sell
154,193
-24,291
-14% -$932K ﹤0.01% 1924
2014
Q1
$7.12M Sell
178,484
-26,317
-13% -$947K ﹤0.01% 1794
2013
Q4
$6.76M Buy
204,801
+2,365
+1% +$73.7K ﹤0.01% 1792
2013
Q3
$5.94M Sell
202,436
-925,979
-82% -$29M ﹤0.01% 1825
2013
Q2
$38M Buy
+1,128,415
New +$34.9M 0.03% 630

Other funds holding DBD

Ameriprise's DBD Position: Q2 2023 in Review

Ameriprise sold out of Diebold Nixdorf Incorporated (DBD) in Q2 2023, closing a stake of 32,333 shares — an estimated $38.8K sold.

Ameriprise first reported a position in DBD in Q2 2013 and held it in 40 quarters. The position peaked at $38M in Q2 2013. 7 funds tracked by Wall St. Rank hold DBD as of Q2 2023.

  • Ameriprise reported no remaining Diebold Nixdorf Incorporated position as of Q2 2023 after selling out during the quarter.
  • Ameriprise sold 32,333 Diebold Nixdorf Incorporated shares in Q2 2023, an estimated $38.8K.
  • Ameriprise first reported a position in Diebold Nixdorf Incorporated in Q2 2013 and held it in 40 quarters.
  • Ameriprise's Diebold Nixdorf Incorporated position peaked at $38M in Q2 2013.
  • 7 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q2 2023.

Based on Ameriprise's 13F filing for Q2 2023, filed 14 Aug 2023.